Compare top Myeloma doctors and prices in Israel. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
9
Israel
Reviews
14,000+
From real patients
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Show first:
Professor Ron Ram practices at Sourasky Medical Center (Ichilov), Israel's largest university hospital.
Dr. Ron Ram has performed several hundred stem cell transplants at Sourasky Medical Center – a key procedure for treating Myeloma.
Dr. El Hasid has conducted over 300 bone marrow and cord blood transplants for children. She leads the Pediatric Oncohematology and Oncology Department at Dana Dwek Children's Hospital.
Dr. Michael Shapira is a senior hematologist known for proving age is no barrier to successful stem cell transplants. He leads the Hematology Inpatient Unit and Day Hospital at Tel Aviv Sourasky Medical Center.
Dr. Fredi Aviv has focused on Myeloma for 34 years of experience at Tel Aviv's major Sourasky Medical Center.
Dr. Dror Levin is a leading expert in pediatric blood disorders and bone cancer, directing the children's hematology oncology department at Sourasky Medical Center.
Dr. Kirshner is actively involved in myeloma research and clinical trials, including phase III trials testing new treatment combinations.
Dr. Yair is an award-winning hematologist at Sourasky Medical Center, specializing in blood cancers like myeloma.
Oncohematologist Ofer Spielberg treats blood cancers at Assuta Medical Center.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
142 patients from Israel have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | 24 years of experience | Myeloma requiring bone marrow transplant | Practices within a premier unit led by Israel's top hemato-oncologists, specializing in transplants and advanced cellular immunotherapy. Colleagues are published international experts. | Israel | Price on request
| |
| #2 | 24 years of experience | Myeloma requiring stem cell transplant | Performs hundreds of stem cell transplants for Myeloma. Combines transplant experience with deep academic expertise, having published over 30 scientific articles. | Israel | Price on request
| |
| #3 | 38 years of experience | Pediatric bone marrow transplants | Over 300 transplant procedures performed – focuses solely on pediatric transplants. Head of the department and member of leading hematology societies. | Israel | Price on request
| |
| #4 | 36 years of experience | Older adult myeloma patients | Pioneer in proving age is no barrier to transplants—successfully treating patients over 70. Senior director at a major academic hospital and recognized for his groundbreaking work. | Israel | Price on request
| |
| #5 | 34 years of experience | Myeloma and complex blood cancers | Oncohematologist with three decades of focused experience at a top-tier medical center, specializing in blood cancer treatment protocols. | Israel | Price on request
| |
| #6 | 41 years of experience | Pediatric bone cancer (sarcoma) | Directs pediatric hematology oncology at Sourasky Medical Center. Trained at Italy's Rizzoli Orthopaedic Institute – a global leader in bone oncology. | Israel | Price on request
| |
| #7 | 32 years of experience | Advanced treatment approaches | Active in developing new myeloma treatments through clinical trials. Fellowship-trained at Montefiore, with dual specialization in hematology and oncology. | Israel | Price on request
| |
| #8 | 24 years of experience | Chronic lymphocytic leukemia | Recognized with multiple awards for hematology research. Member of key professional associations. Specializes in blood cancers with extensive training. | Israel | Price on request
| |
| #9 | Myeloma treatment | Specializes exclusively in myeloma and blood cancers, treating patients at a leading private hospital network in Israel. | Israel | Price on request
|
Israel offers advanced multiple myeloma treatments including in-house developed CAR T-cell therapy, bispecific antibodies, and complex stem cell transplants. Facilities like Sheba Medical Center and Hadassah provide personalized precision medicine. These programs utilize genetic profiling to tailor targeted drug protocols for refractory cases.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba are unique because they perform both pediatric and adult bone marrow transplants at massive scale. Dr. Fredi Aviv has practiced at Sourasky for over 30 years, while Sheba serves nearly 2 million patients annually. This high volume allows doctors to manage complex side effects from aggressive daratumumab combinations more effectively than smaller regional centers.
Patient Consensus: Patients note that access to tandem transplants is often faster in Israel than in the US. Many suggest prioritizing bispecific antibodies over CAR-T if you have limited mobility, as the administration process is simpler.
Israeli clinics achieve CAR-T therapy success rates between 70% and 90% for various blood cancers. Medical centers like Sheba and Hadassah report a 90% overall response rate for multiple myeloma. These results frequently exceed global averages due to advanced in-house cell manufacturing and early clinical adoption.
Bookimed Expert Insight: Israeli centers like Sheba Medical Center offer a distinct advantage through point-of-care manufacturing. While commercial labs usually take 3 to 4 weeks, Sheba's in-house facility delivers cells in roughly 10 days. This speed prevents disease progression during the waiting period. Advanced specialists like Dr. Abraham Avigdor and Dr. Avichai Shimoni lead these high-volume programs with over 30 years of experience.
Patient Consensus: Patients note that while deep remissions are common, it is vital to discuss long-term durability with the medical team. People often emphasize that the faster cell processing in Israel provides significant peace of mind during the critical treatment window.
Israel boasts internationally recognized myeloma specialists at JCI-accredited institutions like Sheba Medical Center and Sourasky Medical Center. These experts include Prof. Avichai Shimoni and Dr. Hila Magen, both leading figures in immunotherapy and stem cell transplantation for plasma cell disorders.
Bookimed Expert Insight: Israeli oncology centers demonstrate high-volume expertise, with Sourasky Medical Center serving 1.8 million patients and maintaining a 90% success rate. Experts like Dr. Hila Magen and Dr. Abraham Avigdor have over 30 years of experience. This deep specialization is why many specialists are listed among Forbes' Top Doctors.
Patient Consensus: Patients note the value of specialists who participate in international clinical trials. Many seek out physicians like Prof. Michael Shapira for personalized bone marrow transplant protocols.
Israel offers numerous clinical trials for relapsed and high-risk myeloma patients. Major centers utilize advanced CAR T-cell therapies and bispecific antibodies. These trials provide access to innovative treatments for those not responding to standard care. Facilities like Sheba Medical Center are global leaders in immunotherapy research.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba have massive patient volumes, exceeding 1,800,000 yearly. This high throughput accelerates trial enrollment and data collection. Patients benefit from a 90% success rate in general oncology at specialized Tel Aviv facilities. Clinicians often combine research with practical care, as seen by their rankings in the global top 10 for consecutive years.
Patient Consensus: Patients value the direct access to Nobel-prize-winning expertise and latest CAR-T protocols. Many emphasize that coordinate Care in Israel feels exceptionally personalized despite the massive size of the hospitals.
Myeloma treatment in Israel typically requires a stay of 1 to 8 weeks depending on the protocol. Diagnostics usually conclude within 5 days. Complex therapies like CAR-T cell infusion require intensive monitoring for approximately 8 weeks. Standard chemo-immunotherapy cycles often allow patients to return home between sessions.
Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba often fast-track international cases to avoid local wait times. While residents may wait significantly longer for elective care, international patients typically begin specialized diagnostics immediately upon arrival. This efficiency is critical for myeloma patients who require rapid intervention after a diagnosis is confirmed.
Patient Consensus: Patients note that staying in a nearby hotel rather than the hospital for follow-up days makes the recovery process much more comfortable and less stressful.